References
- Anderson, S., Hauck, W.–W. (1990). Consideration of individual bioequivalence. Journal of Pharmacokinetics and Biopharmaceutics 18:259–273.
- Chow, S. C. Liu, J.–P. (1997). Meta-analysis for bioequivalence review. Journal of Biopharmaceutical Statistics, 7:97–111.
- Chow, S.–C., Liu, J.–P. (2008). Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Chapman Hall/CRC Press, Taylor and Francis.
- Chow, S.–C., Shao, J. (1999). Bioequivalence review for drug interchangeability. Journal of Biopharmaceutical Statistics, 9:485–497.
- FDA. Guidance for Industry: Bioavailability and Bioequivalence Studies. Rockville, Maryland, USA: Food and Drug Administration.
- Holder, D.–J., Hsuan, F. (1993). Moment-based criteria for determining bioequivalence. Biometrika, 80:835–846.
- Liu, W.–W., Chow, S.–C. (2015). Meta-analysis for safety monitoring of drug interchangeability. Journal of Bioequivalence and Bioavailability, 7:239–243.
- Owen, A.–B. (1988). Empirical likelihood ratio confidence intervals for a single functional. Biometrika, 75:237–249.
- Owen, A.–B. (1990). Empirical likelihood ratio confidence regions. The Annals of Statistics, 18:90–120.
- Owen, A.–B. (2001). Empirical Likelihood. New York, NY: Chapman Hall/CRC Press.
- Schall, R., Luus, H.–G. (1993). On population and individual bioequivalence. Statistics in Medicine, 12:1109–1124.
- Schuirmann, D.–J. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics, 15:657–680.